Charles River Laboratories International, Inc. (NYSE: CRL) announced
today that it will present at the Raymond James 37th Annual
Institutional Investors Conference in Orlando, Florida on Tuesday, March
8th, at 10:25 a.m. ET. Management will present an overview of
Charles River’s strategic focus and business developments.
A live webcast of the presentation will be available through a link that
will be posted on the Investor Relations section of the Charles River
website at ir.criver.com.
A webcast replay will be accessible through the same website
approximately three hours after the presentation and will remain
available for approximately two weeks.
About Charles River
Charles River provides essential products and services to help
pharmaceutical and biotechnology companies, government agencies and
leading academic institutions around the globe accelerate their research
and drug development efforts. Our dedicated employees are focused on
providing clients with exactly what they need to improve and expedite
the discovery, early-stage development and safe manufacture of new
therapies for the patients who need them. To learn more about our unique
portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160307005118/en/
Copyright Business Wire 2016